author-photo

Agostina Nardone

Baylor College of Medicine

47

Papers

876

Citations

Citation Trend

Filter By

Papers (31) Sort By

Journal Conference Others

Activation of the interferon signaling pathway is associated with resistance to CDK4/6 inhibitors and immune checkpoint activation in ER-positive breast cancer.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (4)
Abstract PD8-03: A FOXA1/FRA1-centered transcriptional axis regulates interferon signaling in high FOXA1-associated endocrine-resistant and metastatic breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD7-01: Identification of a high FOXA1-induced pro-metastatic enhancer signature in endocrine-resistant and metastatic breast cancer

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD2-02: Activation of the EGFR/RAS/p42,44 MAPK axis as a convergent mechanism of resistance to CDK4/6 inhibitors in ER+ breast cancer

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract GS2-01: High levels of interferon-response gene signatures are associated withde novoand acquired resistance to CDK4/6 inhibitors in ER+ breast cancer

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Combination of fulvestrant and chemotherapy in ESR1 Y537S mutant breast cancer cells and potential synergy mechanism related to p53 wildtype.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P6-04-02: Integrative cistromic/transcriptomic profiling identifies a high FOXA1/ER-activated pro-metastatic secretome in endocrine-resistant breast cancer

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract B16: Mathematical modeling identifies optimum palbociclib dosing schedules for the treatment of estrogen receptor-positive (ER+) breast cancer patients

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Targeting the mevalonate pathway to overcome acquired anti-HER2 treatment resistance in breast cancer

2019 Molecular Cancer Research
Show All
- Source
- Cite
- Save
Citations (18)
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

2019 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (42)